Literature DB >> 8196628

An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc.

S Gaubatz1, A Meichle, M Eilers.   

Abstract

In RAT1A fibroblasts, expression of the prothymosin alpha gene is under the transcriptional control of the c-myc proto-oncogene. We have now cloned the rat gene encoding prothymosin alpha and show that the cloned gene is regulated by c-myc in vivo. We find that regulation by c-myc is mediated by sequences downstream of the transcriptional start site, whereas the promoter is constitutive and not regulated by c-myc. We have identified an enhancer element within the first intron that is sufficient to mediate a response to Myc and Max in transient transfection assays and to activation of estrogen receptor-Myc chimeras in vivo. We find that this element contains a consensus Myc-binding site (CACGTG). Disruption of this site abolishes the response to Myc and Max in both transient and stable assays. Mutants of either Myc or Max that are deficient for heterodimerization fail to regulate the prothymosin alpha gene, suggesting that a heterodimer between Myc and Max activates the prothymosin alpha gene. Our data define the prothymosin alpha gene as a bona fide target gene for c-myc.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8196628      PMCID: PMC358752          DOI: 10.1128/mcb.14.6.3853-3862.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  68 in total

1.  Prothymosin alpha mRNA levels are invariant throughout the cell cycle.

Authors:  J B Zalvide; E Cancio; C V Alvarez; B J Regueiro; F Dominguez
Journal:  J Biol Chem       Date:  1992-04-25       Impact factor: 5.157

2.  Induction of apoptosis in fibroblasts by c-myc protein.

Authors:  G I Evan; A H Wyllie; C S Gilbert; T D Littlewood; H Land; M Brooks; C M Waters; L Z Penn; D C Hancock
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

3.  The human prothymosin alpha gene family contains several processed pseudogenes lacking deleterious lesions.

Authors:  R E Manrow; A Leone; M S Krug; W H Eschenfeldt; S L Berger
Journal:  Genomics       Date:  1992-06       Impact factor: 5.736

4.  Nuclear localization and DNA binding of the transforming gene product of avian myelocytomatosis virus.

Authors:  P Donner; I Greiser-Wilke; K Moelling
Journal:  Nature       Date:  1982-03-18       Impact factor: 49.962

5.  Nucleotide sequence analysis of the chicken c-myc gene reveals homologous and unique coding regions by comparison with the transforming gene of avian myelocytomatosis virus MC29, delta gag-myc.

Authors:  D K Watson; E P Reddy; P H Duesberg; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

6.  max encodes a sequence-specific DNA-binding protein and is not regulated by serum growth factors.

Authors:  S Berberich; N Hyde-DeRuyscher; P Espenshade; M Cole
Journal:  Oncogene       Date:  1992-04       Impact factor: 9.867

7.  Differential expression of the amv gene in human hematopoietic cells.

Authors:  E H Westin; R C Gallo; S K Arya; A Eva; L M Souza; M A Baluda; S A Aaronson; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

8.  Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29.

Authors:  W W Colby; E Y Chen; D H Smith; A D Levinson
Journal:  Nature       Date:  1983-02-24       Impact factor: 49.962

9.  Expression of cellular homologues of retroviral onc genes in human hematopoietic cells.

Authors:  E H Westin; F Wong-Staal; E P Gelmann; R Dalla-Favera; T S Papas; J A Lautenberger; A Eva; E P Reddy; S R Tronick; S A Aaronson; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

10.  Nuclear location of the putative transforming protein of avian myelocytomatosis virus.

Authors:  H D Abrams; L R Rohrschneider; R N Eisenman
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

View more
  32 in total

1.  Analysis of E-box DNA binding during myeloid differentiation reveals complexes that contain Mad but not Max.

Authors:  K M Ryan; G D Birnie
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene.

Authors:  B C Lewis; H Shim; Q Li; C S Wu; L A Lee; A Maity; C V Dang
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

3.  Overlapping microarray profiles of dentate gyrus gene expression during development- and epilepsy-associated neurogenesis and axon outgrowth.

Authors:  Robert C Elliott; Michael F Miles; Daniel H Lowenstein
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

4.  The interferon-inducible murine p48 (ISGF3gamma) gene is regulated by protooncogene c-myc.

Authors:  X Weihua; D J Lindner; D V Kalvakolanu
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

5.  YY1 and c-Myc associate in vivo in a manner that depends on c-Myc levels.

Authors:  A Shrivastava; J Yu; S Artandi; K Calame
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

6.  A minimal regulatory region maintains constitutive expression of the max gene.

Authors:  M A Peters; K G Sollenberger; T L Kao; E J Taparowsky
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

7.  Myc versus USF: discrimination at the cad gene is determined by core promoter elements.

Authors:  K E Boyd; P J Farnham
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

8.  The c-myc protein represses the lambda 5 and TdT initiators.

Authors:  S Mai; I L Mårtensson
Journal:  Nucleic Acids Res       Date:  1995-01-11       Impact factor: 16.971

9.  Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors.

Authors:  B Roy; J Beamon; E Balint; D Reisman
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

10.  Mad proteins contain a dominant transcription repression domain.

Authors:  D E Ayer; C D Laherty; Q A Lawrence; A P Armstrong; R N Eisenman
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.